- Release Date: 19/10/22 09:10
- Summary: PXS announces positive interim data from myelofibrosis trial
- Price Sensitive: Yes
- Download Document 257.53KB
- Forums
- ASX - By Stock
- SNT
- Ann: PXS announces positive interim data from myelofibrosis trial
Ann: PXS announces positive interim data from myelofibrosis trial
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $26.26M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.2¢ | $4 | 197 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 383913 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 29356 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 452094 | 0.022 |
5 | 1736248 | 0.021 |
11 | 3131008 | 0.020 |
3 | 730000 | 0.019 |
3 | 997999 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 79356 | 2 |
0.025 | 100000 | 1 |
0.027 | 200000 | 1 |
0.028 | 500000 | 1 |
0.029 | 300000 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online